The aim of this project is to develop engineered T cells for osteosarcoma. Osteosarcoma is the most common bone cancer in adolescents and young adults (80% of the patients are younger than 25 years old) but nevertheless are rare cancer. Read more
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease and degeneration of the nigral dopamine neurons is a key pathological feature of the condition. Read more
Despite representing only ~20% of the entire neuronal population in the neocortex, the GABAergic (Gamma-Aminobutyric Acid) inhibitory interneurons play a pivotal role in most cortical functions. Read more
Applications accepted for PhD Only. Background. This project builds on the recent discovery that whole genome sequencing approaches in blood stem and progenitor cells can be used to estimate the number of actively contributing blood stem cells in humans (Lee-Six et al., Nature 2018). Read more
Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy. Read more
Research Group:
Molecular Mechanisms and Long Term Conditions
Reference. SHLS20065. Background. Acute Myeloid Leukaemia (AML) is a common blood cancer in adults; with its incidence increasing with age, AML cases are predicted to double by 2030. Read more
Radiotherapy and many chemotherapies kill cells by damaging DNA. The efficiency of these DNA damaging agents differs between tumour types and individual patients. Read more
Adoptive cell therapy (ACT) using tumour infiltrating lymphocytes (TILs) or genetically redirected T cells are some of the most promising approaches to emerge recently for the treatment of metastatic disease. Read more
Glioblastoma is the most lethal brain cancer in adults. Its poor prognosis is a result of aggressive tumour growth, therapeutic resistance, and tumour heterogeneity at the cellular and genetic level. Read more
Magnetic field hyperthermia (MFH) is currently undergoing clinical trials for use in humans. The research to date has shown the effectiveness of the approach in cells and animal models and the initial results from human trials are promising. Read more
Within the sphere of cancer chemotherapy, many commercialised drugs have been obtained by the synthesis of new compounds, from natural sources or by structural modification of natural products. Read more
Recent research suggests that cancer cells within a tumour represent a highly heterogeneous cell population. In particular many tumours contain small percentage of cells that share several characteristics with stem cells. Read more
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Access to our £6,000 scholarship competition - applications are now open
Get funding opportunities & application tips
Weekly advice, student stories and study fairs
Create your myFindAPhD account to add this PhD to your shortlist to register for this event to receive updates on upcoming events
Due to your Facebook privacy settings, we were unable to create your account at this time. Please select another method to sign up.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
Continue with Facebook
Looking to list your PhD opportunities? Log in here.